The right to own research drives medtech innovation in Sweden
This article was originally published in Clinica
Executive Summary
Sweden’s Stockholm-Uppsala region is ranked as Europe’s third largest life sciences cluster and is home to many established medtech companies, such as Biovitrum, Maquet, Elekta and Phadia. However, the two cities also play host to the next generation of medtech firms. Joseph Harvey visited the region to find out how a specific law is aiding medtech growth there